Shifting the Paradigm of Gout: An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

Trial Profile

Shifting the Paradigm of Gout: An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2015

At a glance

  • Drugs Colchicine (Primary) ; Febuxostat (Primary)
  • Indications Gout
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Dec 2013 Planned end date changed from 1 Mar 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 16 Jul 2012 Planned end date changed from 1 May 2011 to 1 Mar 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top